Pazopanib Accord 400 mg filmom obložene tablete
| Name | Pazopanib Accord 400 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-859471185 |
| Active Substance | pazopanibklorid |
| Composition | jedna filmom obložena tableta sadrži pazopanibklorid što odgovara 400 mg pazopaniba |
| Pharmaceutical Form | Filmom obložena tableta |
| Manufacturer | PharOS MT Ltd, Birzebbugia, Malta
Remedica Ltd., Limassol, Cipar |
| Marketing Authorisation Holder | Accord Healthcare Polska Sp. z o.o., Ul. Tasmowa 7, Mazowieckie, Varšava, Poljska |
| Marketing Authorisation Date | 17.11.2023 |
| MA Period of Validity | 17.11.2028 |
| Classification Number | UP/I-530-09/22-01/132 |
| Registration Number | 381-12-01/70-23-06 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | L01EX03 |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
